High-throughput chip for drug screening in 3D

A simple micro-array chip developed by scientists in China could sharpen the search for new drugs by enabling the high-throughput screening of drug candidates against cells cultured in three dimensions.

Developing new drugs for the treatment of complex diseases such as cancer is an expensive and time consuming process. Often, the first step in designing a new drug is to use high-throughput screening of large chemical libraries to identify compounds that have the desired medicinal effect.

Most cell-based drug screening technologies currently rely on cell cultures grown in two dimensions (i.e. as a flat layer of cells) and require sophisticated robotic systems to seed the cells and administer the drugs. However, Yanan Du and colleagues from Tsinghua University may have revolutionised the process by developing a micro-array chip that can be used to culture three dimensional balls of cells, called spheroids, and administer candidate drugs on a high-throughput scale.

Du’s chip consists of two plates containing arrays of micro-wells. The micro-wells of the first plate contain porous gelatin sponges. Once cells and culture medium are added, these sponges act as a rudimentary extracellular matrix enabling the cells to form spheroids. Meanwhile, the micro-wells of the second plate are filled with potential drug candidates. Pushing the two plates together brings the drug into contact with the spheroids so the effect of the drug on the cells can be observed.

The technique should be accessible to any laboratory with basic cell culture facilities

There are two key advantages to this system. Firstly, cells that are cultured in 3D more closely mimic the tissues in the body than cells grown in 2D. Consequently, the effect that the drug has on these cells is likely to be more representative of the effect that the drug would actually have in the body, making the results of the screening process more reliable. Cells cultured in 3D are also more likely to develop drug resistance so these compounds can be weeded out at an earlier stage in the drug development process. The second advantage is that the technique doesn’t require any expensive or sophisticated equipment, and so should be accessible to any laboratory with basic cell culture facilities.

‘By using microwells they can scale-down the number of cells and the amount of drug they use whilst increasing throughput by having a device compatible with standard laboratory instrumentation,’ says Tony Cass from Imperial College London, UK, who also develops devices for high throughput analysis.

Mario Cabodi, an expert in microfabrication at Boston University in Massachusetts, US, says the chip potentially has a promising future: ‘3D cell culture systems, like the one described here, might be helpful in bridging the gap between in vitro tests and in vivo results.’

Du’s team are now in the process of standardising the chip and are collaborating with drug development companies to perform cell-based tests of potential anti-cancer drugs.

Related Content

The hunt for innovation

31 January 2014 Premium contentFeature

news image

Big pharma companies are embracing a more open and collaborative approach. Nuala Moran discovers who’s working with whom

Fish in chips: growing embryos in microfluidic systems

14 April 2011 News Archive

news image

The world's smallest aquarium bridges the gap between cell assays and whole animal testing

Most Read

Coated nanoparticles show Alzheimer's promise

12 September 2014 News and Analysis

news image

Gold nanoparticles functionalised with amino acid polymer inhibit the growth of amyloid fibres associated with neurodegenerat...

First flexible graphene display paves the way for folding electronics

11 September 2014 News and Analysis

news image

Team behind the bendy e-reader display hope to have a full colour graphene-based smartphone style screen within a year

Most Commented

Does life play dice?

3 September 2014 The Crucible

news image

Philip Ball wonders whether life evolved to exploit quantum phenomena, or if it’s just in our nature

The trouble with boycotts

29 August 2014 Critical Point

news image

Cutting academic ties with a censured state can do more harm than good, says Mark Peplow